Search Results - "Stewart, Michael W."
-
1
The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
Published in Mayo Clinic proceedings (2012)“…Abstract Vascular endothelial growth factor (VEGF) plays an important role in both physiologic and pathologic angiogenesis and contributes to increased…”
Get full text
Journal Article -
2
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
Published in World journal of diabetes (25-08-2016)“…Diabetic retinopathy (DR) is the leading cause of blindness in industrialized countries. Remarkable advances in the diagnosis and treatment of DR have been…”
Get full text
Journal Article -
3
Diabetic macular edema: Evidence-based management
Published in Indian journal of ophthalmology (01-12-2018)“…Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global…”
Get full text
Journal Article -
4
Anti-VEGF Therapy for Diabetic Macular Edema
Published in Current diabetes reports (01-08-2014)“…Vascular endothelial growth factor (VEGF) plays a pivotal role in the development of diabetic macular edema (DME), the leading cause of vision loss among…”
Get full text
Journal Article -
5
A Review of Ranibizumab for the Treatment of Diabetic Retinopathy
Published in Ophthalmology and therapy (01-06-2017)“…Introduction Laser photocoagulation has been the standard treatment for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) for several…”
Get full text
Journal Article -
6
Current management of diabetic tractional retinal detachments
Published in Indian journal of ophthalmology (01-12-2018)“…Twenty-five percent of diabetes-related vision loss stems from complications of proliferative diabetic retinopathy (PDR). Panretinal photocoagulation has been…”
Get full text
Journal Article -
7
Differences in characteristics of Medicare patients treated by ophthalmologists and optometrists
Published in PloS one (14-09-2020)“…To quantify differences in the age, gender, race, and clinical complexity of Medicare beneficiaries treated by ophthalmologists and optometrists in each of the…”
Get full text
Journal Article -
8
Real-world experience of full-thickness traumatic macular hole among young patients
Published in International journal of retina and vitreous (21-02-2024)“…To describe the demographics, clinical, and imaging characteristics, and visual outcomes in young patients with full-thickness traumatic macular hole (TMH)…”
Get full text
Journal Article -
9
Counterfeit Avastin in India: Punish the Criminals, Not the Patients
Published in American journal of ophthalmology (01-10-2016)“…Abstract Purpose To report the recent controversy surrounding the intraocular use of bevacizumab in India and its relationship to the broader problems of…”
Get full text
Journal Article -
10
Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF Survey
Published in Indian journal of ophthalmology (01-02-2021)“…Purpose: The aim of this study was to present the outcomes of the 2018 and 2020 Vitreo-retinal Society of India (VRSI) biosimilars of anti-vascular endothelial…”
Get full text
Journal Article -
11
The Role of Widefield Optical Coherence Tomography Angiography in Assessing the Severity of Diabetic Retinopathy
Published in Ophthalmology and therapy (01-09-2024)“…Introduction Physicians need an accurate understanding of diabetic retinopathy (DR) severity to optimally manage patients. The aim of this prospective study is…”
Get full text
Journal Article -
12
Optimal management of cytomegalovirus retinitis in patients with AIDS
Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2010)“…Cytomegalovirus (CMV) retinitis is the most common cause of vision loss in patients with acquired immunodeficiency syndrome (AIDS). CMV retinitis afflicted 25%…”
Get full text
Journal Article -
13
Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues
Published in Current diabetes reviews (01-07-2012)“…Diabetic mellitus is the leading cause of blindness in working aged patients in developing nations. Due to the buildup of abnormal metabolites from several…”
Get more information
Journal Article -
14
Recent Advancements in Glaucoma Surgery—A Review
Published in Bioengineering (Basel) (01-09-2023)“…Surgery has long been an important treatment for limiting optic nerve damage and minimising visual loss in patients with glaucoma. Numerous improvements,…”
Get full text
Journal Article -
15
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
Published in British journal of ophthalmology (01-09-2012)Get more information
Journal Article -
16
Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration
Published in Mayo Clinic proceedings. Innovations, quality & outcomes (01-08-2024)“…Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the Western world, with a higher prevalence among Europeans and North…”
Get full text
Journal Article -
17
Fires in the Operating Room: Prepare and Prevent
Published in Ophthalmology (Rochester, Minn.) (01-03-2015)Get full text
Journal Article -
18
Updates on the Diagnosis and Management of Glaucoma
Published in Mayo Clinic proceedings. Innovations, quality & outcomes (01-12-2022)“…Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore, general physicians should be familiar with the diagnosis and…”
Get full text
Journal Article -
19
Re-Engineering the Operating Room Using Variability Methodology to Improve Health Care Value
Published in Journal of the American College of Surgeons (01-04-2013)“…Background Variability in flow of patients through operating rooms has a dramatic impact on a hospital's performance and finances. Natural variation…”
Get full text
Journal Article -
20
Off-Label Drug Use: The Bevacizumab Story
Published in Mayo Clinic proceedings (01-03-2013)Get full text
Journal Article